The Mechanism and Latest Research Progress of Blood–Brain Barrier Breakthrough DOI Creative Commons
Fei Wang,

Liujie Qi,

Zhongna Zhang

et al.

Biomedicines, Journal Year: 2024, Volume and Issue: 12(10), P. 2302 - 2302

Published: Oct. 10, 2024

The bloodstream and the central nervous system (CNS) are separated by blood–brain barrier (BBB), an intricate network of blood vessels. Its main role is to regulate environment within brain. primary obstacle for drugs enter CNS low permeability BBB, presenting a significant hurdle in treating brain disorders. In recent years, advancements have been made researching methods breach BBB. However, understanding how penetrate BBB essential drug delivery techniques. Therefore, this article reviews mechanisms breaking through as well current research progress on mechanism.

Language: Английский

Chemical Design Strategy of Ionizable Lipids for In Vivo mRNA Delivery DOI
Zepeng He, Zhijia Liu, Yongming Chen

et al.

ChemMedChem, Journal Year: 2024, Volume and Issue: 19(16)

Published: May 9, 2024

Lipid nanoparticles (LNPs) are the most clinically successful drug delivery systems that have accelerated development of mRNA drugs and vaccines. Among various structural components LNPs, more recent attention has been paid in ionizable lipids (ILs) was supposed as key component determining effectiveness LNPs for vivo delivery. ILs typically comprised three moieties including heads, linkers, hydrophobic tails, which suggested combination different functional groups could produce with diverse chemical structures biological identities. In this concept article, we provide a summary design strategy high-performing IL candidates discuss their structure-activity relationships shifting tissue-selective We also propose an outlook next-generation ILs, enabling broader translation formulated LNPs.

Language: Английский

Citations

3

Therapeutic applications of cell engineering using mRNA technology DOI

Yujia He,

Angus P. R. Johnston, Colin W. Pouton

et al.

Trends in biotechnology, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 1, 2024

Language: Английский

Citations

2

Lipid nanoparticles-based RNA therapies for breast cancer treatment DOI Creative Commons

Luigia Serpico,

Yuewen Zhu,

Renata Faria Maia

et al.

Drug Delivery and Translational Research, Journal Year: 2024, Volume and Issue: 14(10), P. 2823 - 2844

Published: June 3, 2024

Abstract Breast cancer (BC) prevails as a major burden on global healthcare, being the most prevalent form of among women. BC is complex and heterogeneous disease, current therapies, such chemotherapy radiotherapy, frequently fall short in providing effective solutions. These treatments fail to mitigate risk recurrence cause severe side effects that, turn, compromise therapeutic responses patients. Over last decade, several strategies have been proposed overcome these limitations. Among them, RNA-based technologies demonstrated their potential across various clinical applications, notably therapy. However, RNA therapies are still limited by series critical issues like off-target effect poor stability circulation. Thus, novel approaches investigated improve targeting bioavailability formulations achieve an appropriate outcome. Lipid nanoparticles (LNPs) largely proven be advantageous carrier for nucleic acids RNA. This perspective explores recent advances technology with emphasis LNPs’ utilization nanocarriers therapy progresses applications. Graphical

Language: Английский

Citations

1

Emerging Perspectives on Prime Editor Delivery to the Brain DOI Creative Commons
E J Bendavid,

Sina Ramezanian,

Yaoyao Lu

et al.

Pharmaceuticals, Journal Year: 2024, Volume and Issue: 17(6), P. 763 - 763

Published: June 11, 2024

Prime editing shows potential as a precision genome technology, well the to advance development of next-generation nanomedicine for addressing neurological disorders. However, turning in prime editors (PEs), which are macromolecular complexes composed CRISPR/Cas9 nickase fused with reverse transcriptase and guide RNA (pegRNA), brain remains considerable challenge due physiological obstacles, including blood–brain barrier (BBB). This review article offers an up-to-date overview perspective on latest technologies strategies delivery PEs passage through blood barriers. Furthermore, it delves into scientific significance possible therapeutic applications conditions related diseases. It is targeted at clinicians clinical researchers working advancing neuropathologies.

Language: Английский

Citations

1

The Mechanism and Latest Research Progress of Blood–Brain Barrier Breakthrough DOI Creative Commons
Fei Wang,

Liujie Qi,

Zhongna Zhang

et al.

Biomedicines, Journal Year: 2024, Volume and Issue: 12(10), P. 2302 - 2302

Published: Oct. 10, 2024

The bloodstream and the central nervous system (CNS) are separated by blood–brain barrier (BBB), an intricate network of blood vessels. Its main role is to regulate environment within brain. primary obstacle for drugs enter CNS low permeability BBB, presenting a significant hurdle in treating brain disorders. In recent years, advancements have been made researching methods breach BBB. However, understanding how penetrate BBB essential drug delivery techniques. Therefore, this article reviews mechanisms breaking through as well current research progress on mechanism.

Language: Английский

Citations

1